(Q40514881)

21 September 2017

1 reference

title

Cell-cycle regulators and cancer (English)

1 reference

21 September 2017

Kamb A

1

1 reference

21 September 2017

1 April 1995

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

136-140

1 reference

21 September 2017

4

1 reference

21 September 2017

Rules to replicate by

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Mitosis in transition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Ordering S phase and M phase in the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

The effector interactions of p21ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

1 reference

7 January 2021

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Germline p16 mutations in familial melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

P16 gene in uncultured tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

1 reference

https://api.crossref.org/works/10.1016%2FS0168-9525%2800%2989027-7

7 January 2021

10.1016/S0168-9525(00)89027-7

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7732591